Notice of Availability of License; Mutant IHD1 Inhibitors Useful for Treating Cancer

الملخص

The invention Mutant IHD1 Inhibitors Useful for Treating Cancer is owned by an agency of the U.S. Government and is available for licensing and/or co-development in the U.S.